Alpha-adrenergic agonist

Source: Wikipedia, the free encyclopedia.
(Redirected from
Alpha-agonist
)
Alpha adrenergic agonist
Alpha adrenergic receptors of the α subtype
External links
MeSHD000316
Legal status
In Wikidata

Alpha-adrenergic agonists are a class of

adenylate cyclase. Inactivation of adenylate cyclase in turn leads to the inactivation of the secondary messenger cyclic adenosine monophosphate
and induces smooth muscle and blood vessel constriction.

Classes

Norepinephrine (noradrenaline)

Although complete selectivity between receptor agonism is rarely achieved, some agents have partial selectivity. NB: the inclusion of a drug in each category just indicates the activity of the drug at that receptor, not necessarily the selectivity of the drug (unless otherwise noted).

α1 agonist

α1 agonist: stimulates phospholipase C
activity. (vasoconstriction and mydriasis; used as vasopressors, nasal decongestants and during eye exams). Selected examples are:

α2 agonist

alcohol withdrawal
symptoms). Selected examples are:

Nonspecific agonist

Nonspecific agonists act as agonists at both alpha-1 and alpha-2 receptors.

Undetermined/unsorted

The following agents are also listed as agonists by MeSH.[17]

Clinical significance

Alpha-adrenergic agonists, more specifically the auto receptors of alpha 2 neurons, are used in the treatment of glaucoma by decreasing the production of aqueous fluid by the ciliary bodies of the eye and also by increasing uveoscleral outflow. Medications such as clonidine and dexmedetomidine target pre-synaptic auto receptors, therefore leading to an overall decrease in norepinephrine which clinically can cause effects such as sedation, analgesia, lowering of blood pressure and bradycardia. There is also low quality evidence that they can reduce shivering post operatively.[18]

The reduction of the stress response caused by alpha 2 agonists were theorised to be beneficial peri operatively by reducing cardiac complications, however this has shown not to be clinically effective as there was no reduction in cardiac events or mortality but there was an increased incidence of hypotension and bradycardia.[19]

Alpha-2 adrenergic agonists are sometimes prescribed alone or in combination with stimulants to treat ADHD.[20]

See also

References

  1. ISSN 1433-7851
    .
  2. .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. .
  9. ^ Hsu, W. H. and Lu, Z.-X. (1984). Amitraz' induced delay of gastrointestinal transit in mice: Mediated by α2 adrenergic receptors. Drug Development Research, Volume 4 (6), 655- 680.
  10. ^ "Press Announcements - FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults". www.fda.gov. Retrieved 18 May 2018.
  11. PMID 14664351
    .
  12. .
  13. ^ Westfall Thomas C, Westfall David P, "Chapter 6. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems" (Chapter). Brunton LL, Lazo JS, Parker KL: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e: "AccessMedicine | Anatomy and General Functions of the Autonomic and Somatic Motor Nervous Systems". Archived from the original on 2011-09-30. Retrieved 2015-01-24..
  14. PMID 8564227
    .
  15. .
  16. .
  17. ^ MeSH list of agents 82000316
  18. PMID 26256531
    .
  19. .
  20. .

External links